Profilo
Ellen Cavaleri is currently Head-Investor Relations at PTC Therapeutics, Inc. since 2024.
Formerly, worked as Senior VP-Investor Relations & Communications at Lyra Therapeutics, Inc. from 2022 to 2024, and served as Investor Relations Contact at Kadmon Holdings, Inc. Education includes an undergraduate degree from Vanderbilt University and an MBA from New York University.
Posizioni attive di Ellen Cavaleri
| Società | Posizione | Inizio |
|---|---|---|
| PTC THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | 01/11/2024 |
Precedenti posizioni note di Ellen Cavaleri
| Società | Posizione | Fine |
|---|---|---|
| LYRA THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | 01/06/2024 |
| KADMON HOLDINGS, INC. | Contatto Relazioni con gli Investitori | - |
Formazione di Ellen Cavaleri
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
PTC Therapeutics, Inc.
PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Kadmon Holdings, Inc.
Kadmon Holdings, Inc. BiotechnologyHealth Technology Discovers, develops and delivers transformative therapies for unmet medical needs | Health Technology |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lyra Therapeutics, Inc.
Lyra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage therapeutics company which develops and commercializes novel integrated drugs for treatment of patients with ear, nose and throat and ENT diseases | Health Technology |
















